Number of the records: 1

dihematoporfyrínéter

SYS		d017323
LBL		00000nx--j22000003--45--
005		20240119201312.3
100		$a 19920520csloy0103----ba0
152		$b mesh
250		$a dihematoporfyrínéter $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $8 slo
300	1-	$a 93; was DIHEMATOPORPHYRIN ETHER (NM) 1985-92 $8 eng
300	1-	$a Hematoporphyrins (1985-1992) $8 eng
330	1-	$a The purified component of HEMATOPORPHYRIN DERIVATIVE, it consists of a mixture of oligomeric porphyrins. It is used in photodynamic therapy (HEMATOPORPHYRIN PHOTORADIATION); to treat malignant lesions with visible light and experimentally as an antiviral agent. It is the first drug to be approved in the use of PHOTODYNAMIC THERAPY in the United States. $8 eng
450		$a DHP Ether $5 e $8 eng
450		$a Porfimer $5 e $8 eng
450		$a éter dihematoporfyrínový $5 e $8 slo
550		$3 sllk_un_auth*d000970 $Y Antineoplastic Agents $5 P $a antineoplastiká
550		$3 sllk_un_auth*d003879 $Y Dermatologic Agents $5 P $a dermatologiká
550		$3 sllk_un_auth*d017319 $Y Photosensitizing Agents $5 P $a fotosenzibilizátory
550		$3 sllk_un_auth*d006414 $Y Hematoporphyrin Photoradiation $5 F $a fotoradiácia hematoporfyrínová
686		$a D03.383.129.578.840.500.462.400.200
686		$a D03.633.400.909.500.462.400.200
686		$a D04.345.783.500.462.400.200
686		$a D23.767.727.462.400.200
750		$a Dihematoporphyrin Ether $8 eng
801	-0	$a US $b DNLM $c 19920520
801	-2	$a SK $b BA006 $c 19991006
980		$x M

Number of the records: 1